Juno Therapeutics is a biopharma company developing novel cellular immunotherapies based on two distinct and complementary platforms: T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs) technologies.
Tag Archives: CAR
Cellectis – gene-editing
Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).
Cellectis – gene-editing
